Clinical Trials Logo

Varicella clinical trials

View clinical trials related to Varicella.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05526820 Completed - Varicella Clinical Trials

A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine

Start date: April 8, 2021
Phase: Phase 4
Study type: Interventional

This study is a randomized and controlled Phase IV clinical trial.The purpose of this study is to evaluate the immunogenicity and safety of combined immunization with live attenuated varicella vaccine and inactivated hepatitis A vaccine in children aged 12-15 months.

NCT ID: NCT05158777 Completed - Varicella Clinical Trials

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Start date: February 13, 2022
Phase: Phase 3
Study type: Interventional

This is a randomized, blind, controlled clinical trial of live attenuated varicella vaccines manufactured by Shanghai Institute of Biological Products Co.,Ltd. The purpose of this study is to evaluate the immunogenicity and safety of a two doses vaccination of investigational vaccine with 0,28 day and 0,56 day immunization schedule in population aged ≥13 years old.

NCT ID: NCT05150392 Completed - Varicella Clinical Trials

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

Start date: July 11, 2018
Phase: Phase 3
Study type: Interventional

This is an open-labelled clinical trial of live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd .The purpose of this study is to evaluate the immunity persistence of the single-dose primary immunization of live attenuated varicella vaccine on different time points ,and the safety and immunogenicity after the booster immunization

NCT ID: NCT03843632 Completed - Varicella Clinical Trials

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

Start date: March 1, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate the immunogenicity and safety of VARIVAX™ vaccine in healthy Russian children, adolescents, and adults. No formal hypothesis was tested.

NCT ID: NCT03555071 Completed - Varicella Clinical Trials

A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine

Start date: April 7, 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate consistency, immunogenicity and safety of live attenuated varicella vaccines manufactured at commercialized scale in aged 1-3 years children.

NCT ID: NCT03239873 Completed - Varicella Clinical Trials

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

Start date: October 17, 2017
Phase: Phase 3
Study type: Interventional

This study will evaluate the immunogenicity, safety, and tolerability of VARIVAX® (Varicella Virus Vaccine Live) manufactured with a new passage extension (PE34) process compared with the VARIVAX® 2016 commercial process. The primary hypotheses being tested are that antibody response rate and mean antibody titer induced at 6 weeks after a single vaccination by VARIVAX® PE34 Process are non-inferior to those induced by VARIVAX® 2016 commercial process, and that antibody response rate induced by VARIVAX® PE34 Process is acceptable.

NCT ID: NCT03114982 Completed - Varicella Clinical Trials

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

Start date: May 2016
Phase: Phase 2
Study type: Interventional

This study evaluates the immunogenicity and safety of three different potencies of NBP608 and Varivax which are indicated for active immunization for the prevention of varicella. Total of 152 subjects (38 subjects per each treatment arm) of 12 months to 12 years of age are enrolled, and each subject is administered with single dose of vaccine which is randomly assigned.

NCT ID: NCT03114943 Completed - Varicella Clinical Trials

Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age

Start date: July 14, 2016
Phase: Phase 3
Study type: Interventional

This study assesses non-inferiority by comparing seroconversion rate of NBP608 to Varivax which are indicated for active immunization for prevention of varicella. Total of 488 subjects (244 subjects per treatment arm) of 12 months to 12 years of age are enrolled, and each subject is administered with single dose of vaccine which is randomly assigned.

NCT ID: NCT02981836 Completed - Varicella Clinical Trials

A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines

Start date: August 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the protective effect, safety and immunogenicity of a live attenuated varicella vaccine in healthy children.

NCT ID: NCT02965404 Completed - Varicella Clinical Trials

A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children

Start date: April 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety of a live attenuated varicella vaccine in healthy adults, adolescents, and children.